ASMBS Pediatric Metabolic and Bariatric Surgery Guidelines, 2018

Janey S.A. Pratt; Allen Browne; Nancy T. Browne; Matias Bruzoni; Megan Cohen; Ashish Desai; Thomas Inge; Bradley C. Linden; Samer G. Mattar; Marc Michalsky; David Podkameni; Kirk W. Reichard; Fatima Cody Stanford; Meg H. Zeller; Jeffrey Zitsman

doi:10.1016/j.soard.2018.03.019

ASMBS Pediatric Metabolic and Bariatric Surgery Guidelines, 2018

Janey S.A. Pratt, Allen Browne, Nancy T. Browne, Matias Bruzoni, Megan Cohen, Ashish Desai, Thomas Inge, Bradley C. Linden, Samer G. Mattar, Marc Michalsky, David Podkameni, Kirk W. Reichard, Fatima Cody Stanford, Meg H. Zeller, Jeffrey Zitsman

Research output: Contribution to journal › Article › peer-review

341 Citations (Scopus)

331 Downloads (Pure)

Abstract

The ASMBS Pediatric Committee updates their evidence-based guidelines published in 2012, performing a comprehensive literature search (2009-2017) with 1,387 articles and other supporting evidence through February, 2018. The significant increase in data supporting the use of metabolic and bariatric surgery (MBS) in adolescents since 2012 strengthens these guidelines from prior reports. Obesity is recognized as a disease; treatment of severe obesity requires a life-long multidisciplinary approach with combinations of lifestyle changes, nutrition, medications, and MBS. We recommend using modern definitions of severe obesity in children with the CDC age and gender matched growth charts defining class II obesity as 120% of the 95th percentile and class III obesity as 140% of the 95th percentile. Adolescents with Class II obesity and a co-morbidity (listed in the guidelines), or with Class III obesity should be considered for MBS. Adolescents with cognitive disabilities, a history of mental illness or eating disorders that are treated, immature bone growth, or low Tanner stage should not be denied treatment. MBS is safe and effective in adolescents; given the higher risk of adult obesity that develops in childhood, MBS should not be withheld from adolescents when severe co-morbidities such as depressed Health Related Quality of Life score, type 2 diabetes, obstructive sleep apnea, and non-alcoholic steatohepatitis exist. Early intervention can reduce the risk of persistent obesity as well as end organ damage from long standing co-morbidities.

Original language	English
Journal	Surgery for obesity and related diseases
DOIs	https://doi.org/10.1016/j.soard.2018.03.019
Publication status	E-pub ahead of print - 23 Mar 2018

Keywords

pediatric
adolescent
bariatric surgery
metabolic and bariatric surgery
weight loss surgery
type 2 diabetes
guidelines
childhood obesity
adolescent obesity
guidelines for adolescent bariatric surgery
morbid obesity

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.soard.2018.03.019

ASMBS Pediatric Metabolic and_PRATT_Publishedonline23March2018_GREEN AAM (CC BY-NC-ND)Accepted author manuscript, 942 KBLicence: CC BY-NC-ND

Cite this

Pratt, J. S. A., Browne, A., Browne, N. T., Bruzoni, M., Cohen, M., Desai, A., Inge, T., Linden, B. C., Mattar, S. G., Michalsky, M., Podkameni, D., Reichard, K. W., Stanford, F. C., Zeller, M. H., & Zitsman, J. (2018). ASMBS Pediatric Metabolic and Bariatric Surgery Guidelines, 2018. Surgery for obesity and related diseases. Advance online publication. https://doi.org/10.1016/j.soard.2018.03.019

@article{7f9257cc1dd04ded8f651a0f2e3bd8f0,

title = "ASMBS Pediatric Metabolic and Bariatric Surgery Guidelines, 2018",

abstract = "The ASMBS Pediatric Committee updates their evidence-based guidelines published in 2012, performing a comprehensive literature search (2009-2017) with 1,387 articles and other supporting evidence through February, 2018. The significant increase in data supporting the use of metabolic and bariatric surgery (MBS) in adolescents since 2012 strengthens these guidelines from prior reports. Obesity is recognized as a disease; treatment of severe obesity requires a life-long multidisciplinary approach with combinations of lifestyle changes, nutrition, medications, and MBS. We recommend using modern definitions of severe obesity in children with the CDC age and gender matched growth charts defining class II obesity as 120% of the 95th percentile and class III obesity as 140% of the 95th percentile. Adolescents with Class II obesity and a co-morbidity (listed in the guidelines), or with Class III obesity should be considered for MBS. Adolescents with cognitive disabilities, a history of mental illness or eating disorders that are treated, immature bone growth, or low Tanner stage should not be denied treatment. MBS is safe and effective in adolescents; given the higher risk of adult obesity that develops in childhood, MBS should not be withheld from adolescents when severe co-morbidities such as depressed Health Related Quality of Life score, type 2 diabetes, obstructive sleep apnea, and non-alcoholic steatohepatitis exist. Early intervention can reduce the risk of persistent obesity as well as end organ damage from long standing co-morbidities.",

keywords = "pediatric, adolescent, bariatric surgery, metabolic and bariatric surgery, weight loss surgery, type 2 diabetes, guidelines, childhood obesity, adolescent obesity, guidelines for adolescent bariatric surgery, morbid obesity",

author = "Pratt, {Janey S.A.} and Allen Browne and Browne, {Nancy T.} and Matias Bruzoni and Megan Cohen and Ashish Desai and Thomas Inge and Linden, {Bradley C.} and Mattar, {Samer G.} and Marc Michalsky and David Podkameni and Reichard, {Kirk W.} and Stanford, {Fatima Cody} and Zeller, {Meg H.} and Jeffrey Zitsman",

year = "2018",

month = mar,

day = "23",

doi = "10.1016/j.soard.2018.03.019",

language = "English",

journal = "Surgery for obesity and related diseases",

issn = "1550-7289",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - ASMBS Pediatric Metabolic and Bariatric Surgery Guidelines, 2018

AU - Pratt, Janey S.A.

AU - Browne, Allen

AU - Browne, Nancy T.

AU - Bruzoni, Matias

AU - Cohen, Megan

AU - Desai, Ashish

AU - Inge, Thomas

AU - Linden, Bradley C.

AU - Mattar, Samer G.

AU - Michalsky, Marc

AU - Podkameni, David

AU - Reichard, Kirk W.

AU - Stanford, Fatima Cody

AU - Zeller, Meg H.

AU - Zitsman, Jeffrey

PY - 2018/3/23

Y1 - 2018/3/23

N2 - The ASMBS Pediatric Committee updates their evidence-based guidelines published in 2012, performing a comprehensive literature search (2009-2017) with 1,387 articles and other supporting evidence through February, 2018. The significant increase in data supporting the use of metabolic and bariatric surgery (MBS) in adolescents since 2012 strengthens these guidelines from prior reports. Obesity is recognized as a disease; treatment of severe obesity requires a life-long multidisciplinary approach with combinations of lifestyle changes, nutrition, medications, and MBS. We recommend using modern definitions of severe obesity in children with the CDC age and gender matched growth charts defining class II obesity as 120% of the 95th percentile and class III obesity as 140% of the 95th percentile. Adolescents with Class II obesity and a co-morbidity (listed in the guidelines), or with Class III obesity should be considered for MBS. Adolescents with cognitive disabilities, a history of mental illness or eating disorders that are treated, immature bone growth, or low Tanner stage should not be denied treatment. MBS is safe and effective in adolescents; given the higher risk of adult obesity that develops in childhood, MBS should not be withheld from adolescents when severe co-morbidities such as depressed Health Related Quality of Life score, type 2 diabetes, obstructive sleep apnea, and non-alcoholic steatohepatitis exist. Early intervention can reduce the risk of persistent obesity as well as end organ damage from long standing co-morbidities.

AB - The ASMBS Pediatric Committee updates their evidence-based guidelines published in 2012, performing a comprehensive literature search (2009-2017) with 1,387 articles and other supporting evidence through February, 2018. The significant increase in data supporting the use of metabolic and bariatric surgery (MBS) in adolescents since 2012 strengthens these guidelines from prior reports. Obesity is recognized as a disease; treatment of severe obesity requires a life-long multidisciplinary approach with combinations of lifestyle changes, nutrition, medications, and MBS. We recommend using modern definitions of severe obesity in children with the CDC age and gender matched growth charts defining class II obesity as 120% of the 95th percentile and class III obesity as 140% of the 95th percentile. Adolescents with Class II obesity and a co-morbidity (listed in the guidelines), or with Class III obesity should be considered for MBS. Adolescents with cognitive disabilities, a history of mental illness or eating disorders that are treated, immature bone growth, or low Tanner stage should not be denied treatment. MBS is safe and effective in adolescents; given the higher risk of adult obesity that develops in childhood, MBS should not be withheld from adolescents when severe co-morbidities such as depressed Health Related Quality of Life score, type 2 diabetes, obstructive sleep apnea, and non-alcoholic steatohepatitis exist. Early intervention can reduce the risk of persistent obesity as well as end organ damage from long standing co-morbidities.

KW - pediatric

KW - adolescent

KW - bariatric surgery

KW - metabolic and bariatric surgery

KW - weight loss surgery

KW - type 2 diabetes

KW - guidelines

KW - childhood obesity

KW - adolescent obesity

KW - guidelines for adolescent bariatric surgery

KW - morbid obesity

U2 - 10.1016/j.soard.2018.03.019

DO - 10.1016/j.soard.2018.03.019

M3 - Article

SN - 1550-7289

JO - Surgery for obesity and related diseases

JF - Surgery for obesity and related diseases

ER -

ASMBS Pediatric Metabolic and Bariatric Surgery Guidelines, 2018

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this